-
Bioinformatics uses RNA sequencing to guide personalized drug prescription methods for stomach cancer.
Time of Update: 2020-07-19
the first author of the study, Maxim Sorokin, senior researcher of MIPT translational genomics bioinformatics laboratory and director of oncobox bioinformatics department, said: "this study is actually the first case of successfully prescribing [ramiku] for gastric cancer patients, which is not random, but based on our molecular marker analysis based on RNA sequencing tracking.
-
The regulation of arginine metabolism in the microenvironment enhances the therapeutic effect of CAR-T.
Time of Update: 2020-07-19
The resulting low arginine microenvironment also impairs the proliferation of car-t cells and limits their efficacy in clinical trials of solid tumors.
treatment with anti-gd2 car-t cells significantly increased the overall survival rate and the number of enzyme modified car-t cells in peripheral blood.
-
Three-born Jian HER2 single resistance was approved, breast cancer market ushered in a new change.
Time of Update: 2020-07-19
Figure 1: market sales of Roche HER2 monoclonal antibody (unit: million US dollars) in the past two years, in addition to trastuzumab, the market of patuzumab and emmettrazumab showed a high growth trend.
-
Professor Cheng Ying's in-depth interpretation: the advanced way of small cell lung cancer treatment.
Time of Update: 2020-07-19
in addition, new first-line models are also being explored, including a phase III study on the first-line treatment of extensive SCLC with immunotherapy and anti angiogenesis drugs on the basis of chemotherapy, hoping to double regulate the immune microenvironment of SCLC to further increase the therapeutic effect.
-
100% disease control rate! Keytruda immunotherapy combination 1/2 line of treatment in Asian stomach cancer patients with positive results.
Time of Update: 2020-07-19
in this open label, single arm, phase 2 clinical trial, researchers used a combination of keytruda (pembrolizumab), a heavy-weight PD-1 inhibitor from MSD, and lenvima (lenvatinib), a tyrosine kinase inhibitor from Eisai, as a first-line or second-line treatment for patients with advanced gastric cancer.
-
Tragedy! Nature shows that blood cell mutations associated with leukemia are inevitable and there are human differences!
Time of Update: 2020-07-19
, June 27, 2020 /PRNewswire- BIOON/-- A new study by researchers at the Center for Integrated Medical Center (RIKEN IMS) of the Japan Institute of Science and Science has looked at the differences
-
Nano-antibody: anti-tumor treatment of new forces, to help the new crown pneumonia treatment development has great potential for the new observation of the medicine.
Time of Update: 2020-07-19
Nearly 100 authoritative leaders of domestic bio innovative drugs have spoken, hundreds of leading Biopharmaceutical Enterprises have paid close attention to it. More than 1000 pharmaceutical peers ha
-
Nature Sub-Journal: A liquid biopsy can accurately detect early renal cancer.
Time of Update: 2020-07-19
the study, published in the June 22 issue of the journal Nature Medicine, points out that if validated and widely used in larger scale trials, this noninvasive test can detect more undifferentiated early renal cell carcinoma, thereby reducing the mortality of the disease.
-
"Intestinal" short words. Professor Chen Gong case sharing: "Knowing the fate of god, do our best" b-type colon cancer with liver metastasis one case.
Time of Update: 2020-07-19
in this issue, Professor Chen Gong's team shared the diagnosis and treatment process of a case of sigmoid colon cancer with liver metastasis.
Chen Gong: case review and comments: the patient was diagnosed with multiple liver metastases of sigmoid colon cancer in July 2019, and the initial stage was absolutely inoperable.
-
Intermittent fasting promotes chemotherapy for breast cancer, clinical trials appear in The Nature sub-journal.
Time of Update: 2020-07-19
a randomized clinical trial recently published in nature communications showed that a low calorie, low protein and plant-based intermittent diet plan, fasting simulated diet, is a safe and effective auxiliary means for women with early breast cancer, and promotes the response of patients to chemotherapy.
-
More than 70% solid tumor cure rate! The anti-CTLA-4 antibody of the tumor bovine pox virus will be clinical trials at the end of the year.
Time of Update: 2020-07-19
clinical data validation bt-001 is based on the proprietary technology platform of transgene Invir.IO Gamma The new oncolytic virus, vaccinia virus, has been engineered to bind to tumor cells and produce anti CTLA-4 antibody and GM-CSF in the tumor area.
-
How is the preferred treatment for hormone-sensitive prostate cancer?
Time of Update: 2020-07-19
at 25 weeks, 76%, 59% and 80% of patients with PSA ≤ 0.2 ng / ml in AAP + ADT group, APA group and AAP + APA group, respectively.
-
New Findings: Genetically engineered modifications hinder sugar metabolism can slow the growth of lung tumors.
Time of Update: 2020-07-19
the first author of the study, Caroline contat, a student and doctoral assistant at the Swiss Institute of experimental cancer at the Federal Institute of technology in Lausanne, Switzerland, said: "inhibiting the use of sugar in lung tumors may be an effective treatment strategy, but it is not clear whether glucose transporters should be targeted and which glucose transporters should be targeted.
-
CD30 plus lymphoma series . . . CD30 ride the wind and waves hit!
Time of Update: 2020-07-19
Am J Pathol 1995;146:463–71.[8]Swerdlow SH, et al (Eds).
Blood 2016; 128 (12): 1562–1566.[14] Pro, B., et al.
Journal of Clinical Oncology 2012 30:18, 2190-2196.[15] Pro, B., et al.
for medical and health professionals only.
vv-medcom-20158vv-medcom-20159 everyone is doing a little research, move your little finger!
-
Clinical Essentials . . . Oncologists should understand: "The "scale and cure" of non-small cell lung cancer
Time of Update: 2020-07-19
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer(KEYNOTE-010):a randomised controlled trial.
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens.
-
Gastroenterology: An unexpected discovery in hyper-expanded endoscopy monitoring ulcerative colitis. Case studies.
Time of Update: 2020-07-19
therefore, folic acid may have chemopreventive effect on colorectal cancer and can be used as a preventive drug for uc-crc.
analysis of risk factors of ulcerative colitis related colorectal cancer [J].
-
NBE . . . The new anti-tumor nanodrug enables an effective combination of vascular embolism and chemotherapy.
Time of Update: 2020-07-19
This study provides a new idea for the development of new anti-tumor vascular drugs, and has guiding significance for the scheme design of improving the clinical efficacy of embolization therapy.
-
Myelin's common words. Professor Hillengass talks to Professor Cai Zhen about new developments in the treatment of NDMM patients.
Time of Update: 2020-07-19
The results of Griffin study show that the combination of d-rvd and four drugs can significantly improve the deep remission indicators such as MRD negative conversion rate and prolong the survival and benefit of patients.
-
J Neuro-Oncol: Focused ultrasound promises to treat the deadliest brain tumor.
Time of Update: 2020-07-19
, June 29, 2020 /PRNewswire bioON, BioValley, an innovative application of focused ultrasound, pioneered by the University of Virginia School of Medicine, has shown promise to fight malignant glioma
-
Clinical Essentials . . . Summary of the principles of radiation therapy.
Time of Update: 2020-07-19
Sometimes, patients may fail to comply with the doctor's advice due to some external factors such as economy and strong adverse reactions, which not only affects the treatment effect, but also interferes with the follow-up arrangements.
